$GKOS
GLAUKOS Corp

2023 Q3 Form 10-Q Financial Statement

#000155837023012950 Filed on August 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $78.05M $80.40M
YoY Change 9.51% 10.61%
Cost Of Revenue $18.51M $20.10M
YoY Change 9.78% 12.73%
Gross Profit $59.54M $60.30M
YoY Change 9.43% 9.92%
Gross Profit Margin 76.28% 75.0%
Selling, General & Admin $54.25M $52.44M
YoY Change 15.05% 5.08%
% of Gross Profit 91.11% 86.97%
Research & Development $33.30M $36.23M
YoY Change 15.35% 14.26%
% of Gross Profit 55.93% 60.09%
Depreciation & Amortization $8.450M $8.379M
YoY Change 7.04% 6.2%
% of Gross Profit 14.19% 13.9%
Operating Expenses $87.55M $89.37M
YoY Change 15.17% -2.45%
Operating Profit -$28.01M -$29.08M
YoY Change 29.61% -20.91%
Interest Expense $3.398M -$1.505M
YoY Change -2.38% -144.08%
% of Operating Profit
Other Income/Expense, Net -$2.397M -$1.797M
YoY Change -58.08% -79.77%
Pretax Income -$30.41M -$32.38M
YoY Change 11.26% -29.06%
Income Tax $37.00K $435.0K
% Of Pretax Income
Net Earnings -$30.44M -$32.81M
YoY Change 10.4% -27.94%
Net Earnings / Revenue -39.01% -40.81%
Basic Earnings Per Share -$0.63 -$0.68
Diluted Earnings Per Share -$0.63 -$0.68
COMMON SHARES
Basic Shares Outstanding 48.65M 48.21M
Diluted Shares Outstanding 48.68M 48.28M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $300.9M $303.8M
YoY Change -16.79% -22.34%
Cash & Equivalents $108.9M $94.81M
Short-Term Investments $191.9M $209.0M
Other Short-Term Assets $19.60M $18.75M
YoY Change 7.25% 16.97%
Inventory $39.78M $39.45M
Prepaid Expenses
Receivables $39.33M $39.25M
Other Receivables $0.00 $0.00
Total Short-Term Assets $399.5M $401.3M
YoY Change -10.99% -14.82%
LONG-TERM ASSETS
Property, Plant & Equipment $103.1M $175.8M
YoY Change 18.06% 117.24%
Goodwill $66.13M $66.13M
YoY Change 0.0% 0.0%
Intangibles $289.2M $295.4M
YoY Change -7.93% -7.78%
Long-Term Investments
YoY Change
Other Assets $18.70M $18.14M
YoY Change -0.71% -2.13%
Total Long-Term Assets $549.1M $555.5M
YoY Change -1.88% -0.84%
TOTAL ASSETS
Total Short-Term Assets $399.5M $401.3M
Total Long-Term Assets $549.1M $555.5M
Total Assets $948.6M $956.7M
YoY Change -5.93% -7.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.41M $8.564M
YoY Change -9.18% -59.78%
Accrued Expenses $56.73M $55.32M
YoY Change 15.43% 14.74%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $67.15M $63.89M
YoY Change 10.78% -8.09%
LONG-TERM LIABILITIES
Long-Term Debt $353.2M $353.1M
YoY Change -0.05% -0.02%
Other Long-Term Liabilities $12.79M $43.68M
YoY Change 34.75% 362.27%
Total Long-Term Liabilities $12.79M $396.8M
YoY Change 34.75% 4099.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $67.15M $63.89M
Total Long-Term Liabilities $12.79M $396.8M
Total Liabilities $471.0M $467.9M
YoY Change 2.41% -0.19%
SHAREHOLDERS EQUITY
Retained Earnings -$562.3M -$531.8M
YoY Change 29.87% 31.2%
Common Stock $1.039B $1.021B
YoY Change 5.47% 5.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $477.7M $488.8M
YoY Change
Total Liabilities & Shareholders Equity $948.6M $956.7M
YoY Change -5.93% -7.23%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$30.44M -$32.81M
YoY Change 10.4% -27.94%
Depreciation, Depletion And Amortization $8.450M $8.379M
YoY Change 7.04% 6.2%
Cash From Operating Activities -$8.160M -$8.161M
YoY Change -69.22% -33.14%
INVESTING ACTIVITIES
Capital Expenditures $3.360M $5.766M
YoY Change -155.64% -161.33%
Acquisitions
YoY Change
Other Investing Activities $18.26M $31.72M
YoY Change -39.99% 66.66%
Cash From Investing Activities $14.90M $25.95M
YoY Change -38.91% 169.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.470M -880.0K
YoY Change 77.6% -930.19%
NET CHANGE
Cash From Operating Activities -8.160M -8.161M
Cash From Investing Activities 14.90M 25.95M
Cash From Financing Activities 7.470M -880.0K
Net Change In Cash 14.21M 16.91M
YoY Change 582.52% -784.62%
FREE CASH FLOW
Cash From Operating Activities -$8.160M -$8.161M
Capital Expenditures $3.360M $5.766M
Free Cash Flow -$11.52M -$13.93M
YoY Change -43.74% 396.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.85
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48281000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47356000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48082000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47205000
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Registrant Name
EntityRegistrantName
GLAUKOS Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001192448
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37463
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0945406
dei Entity Address Address Line1
EntityAddressAddressLine1
One Glaukos Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Aliso Viejo
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92656
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
367-9600
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
GKOS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48649562
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94812000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119525000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
208995000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
233170000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39252000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36073000
CY2023Q2 us-gaap Inventory Net
InventoryNet
39447000
CY2022Q4 us-gaap Inventory Net
InventoryNet
37841000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18754000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17250000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
401260000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
443859000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5856000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7078000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102674000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
94403000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27726000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25826000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
45391000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
46601000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
295412000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
307869000
CY2023Q2 us-gaap Goodwill
Goodwill
66134000
CY2022Q4 us-gaap Goodwill
Goodwill
66134000
CY2023Q2 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
12287000
CY2022Q4 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
10613000
CY2023Q2 us-gaap Assets
Assets
956740000
CY2022Q4 us-gaap Assets
Assets
1002383000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
8564000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14403000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
55322000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57956000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
63886000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
72359000
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
282087000
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
281400000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30770000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28905000
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
71023000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
72172000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7258000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7264000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12905000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10278000
CY2023Q2 us-gaap Liabilities
Liabilities
467929000
CY2022Q4 us-gaap Liabilities
Liabilities
472378000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48413000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47782000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48385000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47754000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
48000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
48000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1021126000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
997470000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-387000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2975000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-531844000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-464406000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28000
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
132000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
132000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
488811000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
530005000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
956740000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1002383000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
80399000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72685000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
154298000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140366000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20103000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17833000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38174000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
34896000
CY2023Q2 us-gaap Gross Profit
GrossProfit
60296000
CY2022Q2 us-gaap Gross Profit
GrossProfit
54852000
us-gaap Gross Profit
GrossProfit
116124000
us-gaap Gross Profit
GrossProfit
105470000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53137000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49900000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
106787000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
93849000
CY2023Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
33234000
CY2022Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
31712000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
68405000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
58589000
CY2023Q2 gkos Research And Development In Process Expense
ResearchAndDevelopmentInProcessExpense
3000000
CY2022Q2 gkos Research And Development In Process Expense
ResearchAndDevelopmentInProcessExpense
10000000
gkos Research And Development In Process Expense
ResearchAndDevelopmentInProcessExpense
3000000
gkos Research And Development In Process Expense
ResearchAndDevelopmentInProcessExpense
10000000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
30000000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
89371000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
91612000
us-gaap Operating Expenses
OperatingExpenses
178192000
us-gaap Operating Expenses
OperatingExpenses
132438000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-29075000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-36760000
us-gaap Operating Income Loss
OperatingIncomeLoss
-62068000
us-gaap Operating Income Loss
OperatingIncomeLoss
-26968000
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
1894000
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
384000
us-gaap Interest And Other Income
InterestAndOtherIncome
3542000
us-gaap Interest And Other Income
InterestAndOtherIncome
671000
CY2023Q2 us-gaap Interest Expense
InterestExpense
3399000
CY2022Q2 us-gaap Interest Expense
InterestExpense
3414000
us-gaap Interest Expense
InterestExpense
6807000
us-gaap Interest Expense
InterestExpense
6830000
CY2023Q2 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-1797000
CY2022Q2 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-5851000
gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-1269000
gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-6811000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3302000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8881000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4534000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12970000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32377000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45641000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-66602000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39938000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
435000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-105000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
836000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
221000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-32812000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-45536000
us-gaap Net Income Loss
NetIncomeLoss
-67438000
us-gaap Net Income Loss
NetIncomeLoss
-40159000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.85
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48281000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47356000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48082000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47205000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-32812000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-45536000
us-gaap Net Income Loss
NetIncomeLoss
-67438000
us-gaap Net Income Loss
NetIncomeLoss
-40159000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
364000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
666000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
261000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1158000
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
574000
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-994000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2327000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4888000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
938000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-328000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2588000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3730000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31874000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45864000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-64850000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43889000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
530005000
CY2023Q1 gkos Stock Issued During Period Value Share Based Compensation Net
StockIssuedDuringPeriodValueShareBasedCompensationNet
1301000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10184000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1650000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-34626000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
508514000
CY2023Q2 gkos Stock Issued During Period Value Share Based Compensation Net
StockIssuedDuringPeriodValueShareBasedCompensationNet
-702000
CY2023Q2 gkos Adjustments To Additional Paid In Capital Value Of Shares Issued For Acquired In Process Research And Development
AdjustmentsToAdditionalPaidInCapitalValueOfSharesIssuedForAcquiredInProcessResearchAndDevelopment
3000000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9873000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
938000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-32812000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
488811000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
587151000
CY2022Q1 gkos Stock Issued During Period Value Share Based Compensation Net
StockIssuedDuringPeriodValueShareBasedCompensationNet
1515000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6923000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3402000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
5377000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
597564000
CY2022Q2 gkos Stock Issued During Period Value Share Based Compensation Net
StockIssuedDuringPeriodValueShareBasedCompensationNet
238000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10539000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-328000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-45536000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
562477000
us-gaap Profit Loss
ProfitLoss
-67438000
us-gaap Profit Loss
ProfitLoss
-40159000
us-gaap Depreciation
Depreciation
4229000
us-gaap Depreciation
Depreciation
3044000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12456000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12456000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2181000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2296000
gkos Amortization Of Financing Cost
AmortizationOfFinancingCost
687000
gkos Amortization Of Financing Cost
AmortizationOfFinancingCost
687000
gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-6000
gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-12000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
35000
us-gaap Share Based Compensation
ShareBasedCompensation
20057000
us-gaap Share Based Compensation
ShareBasedCompensation
17462000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-97000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2269000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
-342000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
442000
gkos Increase Decrease In Others Accrued Liabilities
IncreaseDecreaseInOthersAccruedLiabilities
2353000
gkos Increase Decrease In Others Accrued Liabilities
IncreaseDecreaseInOthersAccruedLiabilities
-45000
gkos In Process Research And Development Acquired Through Issuance Of Stock
InProcessResearchAndDevelopmentAcquiredThroughIssuanceOfStock
3000000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3100000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3296000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2283000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5151000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-1468000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-602000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9525000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8367000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-177000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
155000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38925000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2432000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
170070000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
36938000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
196913000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
56748000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12674000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16005000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
96000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12119000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3733000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2314000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1921000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
2163000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1785000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3878000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1954000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
327000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
236000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
272000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1516000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
599000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1260000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25935000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1557000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126603000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110124000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100668000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111681000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
780000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
240000
gkos Interest Paid Net Convertible Senior Notes
InterestPaidNetConvertibleSeniorNotes
3953000
gkos Interest Paid Net Convertible Senior Notes
InterestPaidNetConvertibleSeniorNotes
3953000
us-gaap Interest Paid Net
InterestPaidNet
2161000
us-gaap Interest Paid Net
InterestPaidNet
2191000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3080000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3310000
CY2023Q2 gkos Adjustments To Additional Paid In Capital Value Of Shares Issued For Acquired In Process Research And Development
AdjustmentsToAdditionalPaidInCapitalValueOfSharesIssuedForAcquiredInProcessResearchAndDevelopment
3000000.0
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates and assumptions used in the preparation of the accompanying condensed consolidated financial statements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company’s condensed consolidated financial statements as of and for the three and six months ended June 30, 2023 reflect the Company’s estimates of the impact of the macroeconomic environment, including the impact of inflation, higher interest rates and foreign exchange rate fluctuations. The duration and scope of these conditions cannot be predicted; therefore, the extent to which these conditions will directly or indirectly impact the Company’s business, results of operations and financial condition is uncertain.</p>
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94812000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119525000
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
5856000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
7078000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100668000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126603000
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
211224000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
19000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2248000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
208995000
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
237724000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4557000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
233170000
CY2023Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
40787000
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
37323000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1535000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1250000
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
39252000
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
36073000
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
15776000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13742000
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
10611000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
10495000
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
13060000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
13604000
CY2023Q2 us-gaap Inventory Gross
InventoryGross
39447000
CY2022Q4 us-gaap Inventory Gross
InventoryGross
37841000
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
9842000
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
17219000
CY2023Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
5086000
CY2022Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
4475000
CY2023Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
4059000
CY2022Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2329000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
36335000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
33933000
CY2023Q2 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
55322000
CY2022Q4 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
57956000
CY2023Q2 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
CY2022Q4 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1930000
CY2023Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
2535000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3547000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
5184000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3684000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
5340000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3720000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
5500000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3832000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
5665000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3928000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
5835000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
32560000
CY2023Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
96055000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
53201000
CY2023Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
126114000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
21180000
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
54270000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
32021000
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
71844000
CY2023Q2 gkos Lessee Operating Lease Option To Extend Value
LesseeOperatingLeaseOptionToExtendValue
22600000
CY2023Q2 gkos Lessee Financing Lease Option To Extend Value
LesseeFinancingLeaseOptionToExtendValue
75800000
us-gaap Lessee Operating Lease Lease Not Yet Commenced Existence Of Option To Extend
LesseeOperatingLeaseLeaseNotYetCommencedExistenceOfOptionToExtend
true
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
89788000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
176512000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
77331000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
188969000
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
385200000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
89788000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
295412000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
385200000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
77331000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
307869000
CY2023Q2 us-gaap Goodwill
Goodwill
66134000
CY2023Q2 us-gaap Goodwill
Goodwill
66134000
CY2022Q4 us-gaap Goodwill
Goodwill
66134000
CY2022Q4 us-gaap Goodwill
Goodwill
66134000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
12456000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
24618000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
22092000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
22092000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
22081000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
73173000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
176512000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
80399000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
72685000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
154298000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140366000
gkos Period For Payment On Invoice Terms
PeriodForPaymentOnInvoiceTerms
P30D
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8539000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8812000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8560000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8545000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9873000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10539000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20057000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17462000
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
85800000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0134
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0125
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
30900000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
29000000.0
CY2023Q2 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
5600000
CY2022Q4 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
6800000
CY2023Q2 gkos Number Of Months Of Lease Term For Adjustments Of Letters Of Credit Balance Outstanding To Begin
NumberOfMonthsOfLeaseTermForAdjustmentsOfLettersOfCreditBalanceOutstandingToBegin
37
gkos Adjustment Percentage Of Letters Of Credit Balance Outstanding
AdjustmentPercentageOfLettersOfCreditBalanceOutstanding
0.20
CY2023Q2 gkos Minimal Amount Of Letters Of Credit Balance Outstanding After Adjustments
MinimalAmountOfLettersOfCreditBalanceOutstandingAfterAdjustments
2000000.0
CY2023Q2 gkos Number Of Other Irrevocable Letters Of Credit Outstanding
NumberOfOtherIrrevocableLettersOfCreditOutstanding
1
CY2022Q4 gkos Number Of Other Irrevocable Letters Of Credit Outstanding
NumberOfOtherIrrevocableLettersOfCreditOutstanding
1
CY2023Q2 gkos Restricted Cash Pledged For Office Lease Agreement
RestrictedCashPledgedForOfficeLeaseAgreement
200000
CY2022Q4 gkos Restricted Cash Pledged For Office Lease Agreement
RestrictedCashPledgedForOfficeLeaseAgreement
200000
CY2023Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
10400000
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
8200000
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
8200000
CY2023Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
10500000
CY2022Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
8400000
gkos Number Of Business Activities
NumberOfBusinessActivities
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001558370-23-012950-index-headers.html Edgar Link pending
0001558370-23-012950-index.html Edgar Link pending
0001558370-23-012950.txt Edgar Link pending
0001558370-23-012950-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gkos-20230630.xsd Edgar Link pending
gkos-20230630x10q.htm Edgar Link pending
gkos-20230630xex31d1.htm Edgar Link pending
gkos-20230630xex31d2.htm Edgar Link pending
gkos-20230630xex32d1.htm Edgar Link pending
gkos-20230630xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
gkos-20230630_cal.xml Edgar Link unprocessable
gkos-20230630_def.xml Edgar Link unprocessable
gkos-20230630_lab.xml Edgar Link unprocessable
gkos-20230630_pre.xml Edgar Link unprocessable
gkos-20230630x10q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable